Societal CDMO, Inc. Active Patents
2 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2018-04-11: Application 15950367; Invention NANOPARTICULATE MELOXICAM FORMULATIONS; Applicant Recro Pharma, Inc.; Status Patented Case.
- 2017-02-21: Application 15437534; Invention NANOPARTICULATE MELOXICAM FORMULATIONS; Applicant Recro Pharma, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-04-11 | 15950367 | NANOPARTICULATE MELOXICAM FORMULATIONS | Recro Pharma, Inc. | Patented Case | 2019-11-05 | 10463673 | US20180228809A1 | Eugene R. Cooper Tuula Ryde John Pruitt Laura Kline | United States United States United States United States | TRAN, SUSAN T |
| 2017-02-21 | 15437534 | NANOPARTICULATE MELOXICAM FORMULATIONS | Recro Pharma, Inc. | Patented Case | 2019-11-12 | 10471067 | US20170157061A1 | Eugene R. Cooper Tuula Ryde John Pruitt Laura Kline | United States United States United States United States | TRAN, SUSAN T |